Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/4293857

Documents

Beta release

Statistics of Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis
Statistics for this year
PeriodVisitsDownloads
2026109
Statistics for the last 3 months
PeriodVisitsDownloads
2026-0377
2026-0400
2026-0532